| Primary |
| Hepatitis C |
57.3% |
| Product Used For Unknown Indication |
18.4% |
| Chronic Hepatitis C |
13.3% |
| Hypertension |
2.3% |
| Hiv Infection |
1.6% |
| Diabetes Mellitus |
0.9% |
| Hepatic Cirrhosis |
0.8% |
| Anaemia |
0.8% |
| Depression |
0.7% |
| Hypothyroidism |
0.5% |
| Prophylaxis |
0.5% |
| Pruritus |
0.4% |
| Pain |
0.4% |
| Anxiety |
0.4% |
| Hepatitis |
0.3% |
| Hepatitis C Virus Test Positive |
0.3% |
| Insomnia |
0.3% |
| Type 2 Diabetes Mellitus |
0.3% |
| Varices Oesophageal |
0.2% |
| Antiretroviral Therapy |
0.2% |
|
| Rash |
33.4% |
| Thrombocytopenia |
10.0% |
| Vomiting |
8.0% |
| Rash Generalised |
4.6% |
| Off Label Use |
3.8% |
| Pruritus |
3.6% |
| Weight Decreased |
3.5% |
| Neutropenia |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.0% |
| Pyrexia |
2.8% |
| Urinary Tract Infection |
2.8% |
| Anaemia |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
| Skin Reaction |
2.4% |
| Pancytopenia |
2.2% |
| Rash Maculo-papular |
2.2% |
| Sepsis |
2.2% |
| Nausea |
2.0% |
| Blood Creatinine Increased |
1.8% |
|
| Secondary |
| Hepatitis C |
56.8% |
| Product Used For Unknown Indication |
16.8% |
| Chronic Hepatitis C |
13.2% |
| Hepatic Cirrhosis |
2.5% |
| Hiv Infection |
1.8% |
| Hypertension |
1.5% |
| Chronic Hepatitis |
1.0% |
| Anaemia |
1.0% |
| Depression |
1.0% |
| Hepatitis Viral |
0.8% |
| Hepatitis C Virus Test Positive |
0.6% |
| Hepatitis |
0.5% |
| Viral Hepatitis Carrier |
0.4% |
| Hypothyroidism |
0.4% |
| Immunosuppressant Drug Therapy |
0.4% |
| Liver Disorder |
0.4% |
| Pruritus |
0.4% |
| Diabetes Mellitus |
0.3% |
| Fibrosis |
0.3% |
| Haemophilia |
0.3% |
|
| Rash |
20.2% |
| Vomiting |
10.9% |
| Thrombocytopenia |
9.7% |
| Rash Generalised |
5.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.9% |
| Pruritus |
4.9% |
| Off Label Use |
4.5% |
| Weight Decreased |
4.5% |
| Toxic Skin Eruption |
4.0% |
| Nausea |
3.2% |
| Renal Failure Acute |
3.2% |
| Overdose |
2.8% |
| Rash Maculo-papular |
2.8% |
| Renal Failure |
2.8% |
| Septic Shock |
2.8% |
| Syncope |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Pancytopenia |
2.4% |
| Swelling Face |
2.4% |
| Vision Blurred |
2.4% |
|
| Concomitant |
| Hepatitis C |
45.0% |
| Chronic Hepatitis C |
22.5% |
| Product Used For Unknown Indication |
10.0% |
| Hepatitis C Antibody Positive |
3.8% |
| Anaemia |
2.5% |
| Asthma |
2.5% |
| Hepatic Cirrhosis |
2.5% |
| Hiv Infection |
2.5% |
| Hypothyroidism |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Chemotherapy |
1.3% |
| Hypertension |
1.3% |
| Urinary Tract Infection |
1.3% |
|
| Epistaxis |
8.7% |
| Pyrexia |
8.7% |
| Stomatitis |
8.7% |
| Angioedema |
4.3% |
| Ascites |
4.3% |
| Back Pain |
4.3% |
| Catatonia |
4.3% |
| Delirium |
4.3% |
| Depression |
4.3% |
| Encephalopathy |
4.3% |
| Feeling Hot |
4.3% |
| General Physical Health Deterioration |
4.3% |
| Malaise |
4.3% |
| Myalgia |
4.3% |
| Neutropenia |
4.3% |
| Overdose |
4.3% |
| Rash Pruritic |
4.3% |
| Renal Failure Acute |
4.3% |
| Skin Exfoliation |
4.3% |
| Staphylococcal Sepsis |
4.3% |
|
| Interacting |
| Hepatitis C |
33.3% |
| Chronic Hepatitis C |
27.5% |
| Product Used For Unknown Indication |
9.8% |
| Hepatitis |
5.9% |
| Hiv Infection |
5.9% |
| Diabetes Mellitus |
3.9% |
| Anaemia |
2.0% |
| Blood Pressure |
2.0% |
| Blood Pressure Increased |
2.0% |
| Liver Transplant |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Urinary Tract Infection |
2.0% |
| Viraemia |
2.0% |
|
| Drug Interaction |
18.2% |
| Renal Failure Acute |
18.2% |
| Vision Blurred |
18.2% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
9.1% |
| Immunosuppressant Drug Level Increased |
9.1% |
| Pancreatitis Acute |
9.1% |
| Proctalgia |
9.1% |
| Rash Generalised |
9.1% |
|
